Nicole M. Kettner, PhD

[Tvardi Therapeutics @tvarditherap]

https://t.co/34ed2Fdqiv

[Nicole M. Kettner, PhD @kettnernm]

Excited to be at #AACR22 with first-timers @junay_14 and @ndttuyen

[Nicole M. Kettner, PhD @kettnernm]

Starting off the morning at the opening ceremony with the Preservation Hall All-Stars Jazz Band #AACR22

[Sofia Mastoraki @SofiaMast1]

Excited to attend #AACR22 in person and be recipient of the Doreen J. Putrah Scholar-In-Training award 🏆

With @kettnernm

[Nicole M. Kettner, PhD @kettnernm]

I am honored to have been selected as one of the recipients of the AACR John and Elizabeth Leonard Family Foundation Scholar-in-training award #AACR22

[Nicole M. Kettner, PhD @kettnernm]

Excited to be collaborating with @tvarditherap for the preclinical assessment of TTI-101 in MBC. Looking forward to presenting our work at #AACR22

[Tvardi Therapeutics @tvarditherap]

Tvardi is pleased to announce our collaborators (@kandymarsy @DrDebuTripathy) @MDAndersonNews will present preclinical data demonstrating TTI-101 overcomes palbociclib resistance in preclinical models of #metastaticbreastcancer at the upcoming 2022 @AACR https://t.co/w5BmkthVeG